Danaher $21.4 billion acquisition of GE's biopharma business

25/2/2019

Asset acquisition

Value:

$ 21.4 billion

Status:

Announced

Date:

25/2/2019

Overview:

Danaher has acquired General Electric's biopharma business in a $21.4 billion deal.
The business will operate as a stand-alone company.
The transaction is expected to close in the fourth quarter.

Kurt Stumpo - US Editor

Jurisdiction:

United States

Deal type:

Asset acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firm:

Paul Weiss Rifkind Wharton & Garrison

Party: General Electric (Seller)

Lawyers: Scott Barshay, Steven Williams

Related deals